Format

Send to

Choose Destination
Anticancer Res. 2006 Jul-Aug;26(4A):2735-41.

1alpha,25-Dihydroxyvitamin D3 modulates the response of human keratinocytes to ionizing radiation exposure.

Author information

1
Bundeswehr Institute of Radiobiology, Neuherbergstr. 11, D-80937 Munich, Germany. kerstin2mueller@bundeswehr.org

Abstract

BACKGROUND:

Exposure of human skin to ionizing radiation may result in various effects such as inflammation, keratosis, fibrosis and cancer. 1alpha,25-Dihydroxyvitamin D3 (1alpha,25(OH)2D3), the biologically active metabolite of vitamin D, has been shown to exert pleiotropic effects on the skin. The aim of the study was to evaluate the effect of 1alpha,25(OH)2D3 on the radiation response of human keratinocytes.

MATERIALS AND METHODS:

Keratinocytes (HaCaT), either untreated or pretreated with 1alpha,25(OH)2D3, were irradiated with 0-7.5 Gy. Growth curves were generated to determine cell proliferation. Cell survival was examined using a clonogenic assay. The cell surface expression of adhesion molecules was investigated by flow cytometry.

RESULTS:

The cell growth and clonogenic survival of irradiated keratinocytes were both significantly increased by 1alpha,25(OH)2D3. Ionizing radiation caused an up-regulation of the cell surface expression of intercellular adhesion molecule-1 (ICAM-1) and integrins beta1 (CD29), alpha2 (CD49b), alpha5 (CD49e) and alpha6 (CD49f) in keratinocytes, which was inhibited by 1alpha,25(OH)2D3.

CONCLUSION:

The data suggest that 1alpha,25(OH)2D3 may be a promising agent to modify the radiation reaction, thus offering new options in radiotherapy and oncology.

PMID:
16886685
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center